MCL1 and pancreatic neoplasm: In contrast, chidamide treatment had no effect on the mRNA levels of Mcl-1 in pancreatic cancer cell lines, as measured by qPCR assay (Fig 1B), suggesting that chidamide decreased Mcl-1 expression via a post-transcriptional process rather than a transcriptional process.